Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q17RS7 (Gen)
 130,125 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In order to examine the relationship of dyspnea to anxiety and depression, the authors rated dyspnea using several methods in 50 patients with chronic respiratory impairment. Anxiety and depression were measured by the Symptom Checklist-90 and the Symptom Questionnaire. Results varied with the method of assessing dyspnea. Physician-rated dyspnea was significantly associated with patients' self-ratings of breathlessness as well as with pulmonary function tests, but not with any of the self-rating scales of emotions. Self-rated breathlessness was significantly associated with self-rated depression. In multiple regression analyses, depression was predictive of breathlessness. When the sample was limited to patients with chronic obstructive pulmonary disease, the results remained the same. The patients were significantly more depressed and anxious than matched family practice patients. In the study of the complex relationship of dyspnea to physical and emotional factors, it is desirable to use more than one measure of dyspnea because the results depend in part on the method of assessment.
Gen Hosp Psychiatry 1992 Jan
PMID:Dyspnea, anxiety, and depression in chronic respiratory impairment. 173 Mar 97

1. Neuroleptic drugs (antipsychotics) produce numerous side effects which include serious extrapyramidal symptoms consisting of akathisia, dystonia, neuroleptic malignant syndrome, parkinsonian reactions such as postural abnormality, tremor, akinesia or bradykinesia, rigidity, and tardive dyskinesia. 2. Among the complications of neuroleptic chemotherapy, the most serious and potentially fatal complication is malignant syndrome, which is characterized by extreme hyperthermia, "lead pipe" skeletal muscle rigidity causing dyspnea, dysphagia, and rhabdomyolysis, autonomic instability, fluctuating consciousness, leukocytosis, and elevated creatine phosphokinase. 3. Neuroleptic malignant syndrome should be differentiated from malignant hyperthermia, lethal catatonia, and other pathological states producing some of these same symptoms. 4. In addition to neuroleptics, malignant syndrome has been caused by thymoleptics (antidepressants), metoclopramide (antiemetic), metoclopramide combined with cimetidine, tetrabenazine, overdosage of benzodiazepine, phenelzine, dothiepin and alcohol, and amphetamine. 5. Factors leading to and/or facilitating the emergence of neuroleptic malignant syndromes are reportedly organic brain syndrome, dehydration, exhaustion, external heat load, excessive sympathetic discharge, use of long acting neuroleptics, high doses of neuroleptics, rapid dose titration with neuroleptics, abrupt discontinuation of antiparkinsonism agents, and concurrent lithium therapy. 6. Although, the pathogenesis of neuroleptic malignant syndrome is not understood completely, a blockade of dopaminergic receptors in the hypothalamus, spinal cord and striatum, an alteration of dopaminergic-serotonergic transmission in the body, an enhanced synthesis and action of prostaglandin E1 and E2, and a modification of calcium-mediated signal transduction in the body have been suggested. 7. The treatment of malignant syndrome includes immediate withdrawal of neuroleptic drugs, i.v. infusion of dantrolene, and oral administration of bromocriptine; or alternatively i.v. infusion of dantrolene and the combination of levodopa-carbidopa. 8. Other measures to enhance the therapeutic effectiveness of the aforementioned regimens are to include the use of anticholinergic drugs such as benztropine to enhance the effectiveness of bromocriptine, of lorazepam if catatonic symptoms persist, or of electroconvulsive therapy (ECT) if psychotic symptoms persist. 9. These treatments, however, must be "active" rather than "passive", in order to avert fatalities and/or unfortunate sequelae from this iatrogenic and incompletely understood disease.
Gen Pharmacol 1990
PMID:Pathogenesis and treatment of neuroleptic malignant syndrome. 197 19

The authors developed a new measure of subjective health status for patients with heart failure. Eighty-eight patients with heart failure were asked about the impact of their condition on 123 items related to physical and emotional function. The most frequently chosen and important items were included in a 16-item Chronic Heart Failure Questionnaire (CHQ) that examines dyspnea during daily activities, fatigue, and emotional function. The CHQ was tested in a controlled trial of digoxin in heart failure patients in sinus rhythm. When administered serially to 25 patients in the run-in phase of the trial, the CHQ proved reproducible. Subsequently, CHQ results distinguished those who reported improvement or deterioration from those who did not. The CHQ showed moderate correlations with patient global ratings, walk test scores, and clinical assessments of heart failure. The authors conclude that the CHQ may be useful for measuring health status in clinical trials in heart failure.
J Gen Intern Med
PMID:Development and testing of a new measure of health status for clinical trials in heart failure. 270 67

In a prospective study sera from 140 patients with symptoms suggesting a post-viral syndrome and sera from 100 controls were tested for neutralizing antibodies to Coxsackie B viruses. Sixty-five of the patients (46%) and 25 of the controls (25%) had significant antibody titres. The 65 positive cases who had presented with symptoms were followed up and retested six months later and again after one year. Of these 65 patients 36 (55%) were still unwell after one year and high antibody titres persisted in all but two of the patients. Recovery was not found to correlate with a fall in antibody level, but was more rapid in patients whose presenting symptoms were paraesthesiae, anorexia or dyspnoea. The importance of correctly identifying patients with the post-viral syndrome, who may otherwise be labelled neurotic, is emphasized.
J R Coll Gen Pract 1987 Jan
PMID:Coxsackie B viruses and the post-viral syndrome: a prospective study in general practice. 366 15

The diagnostic usefulness of the medical history may depend on the type of problem confronted. It has been suggested that dyspnea is an example of a condition the causes of which cannot be easily distinguished based on identification in the history of stereotypical disease patterns presented in standard texts. To evaluate this assertion, faculty members independently interviewed 146 consecutively admitted patients with dyspnea, and following the history of the present illness, made a diagnosis. After discharge of the patients, another faculty member, using preselected criteria, independently reviewed each record to make a final diagnosis. History-based diagnoses predicted final diagnoses 74% of the time. Therefore, the history appeared to be useful in identifying the primary diagnosis for most dyspneic patients admitted to the hospital. However, it is not known whether this identification provides sufficient rationale for therapy or leads to more efficient use of laboratory tests.
J Gen Intern Med
PMID:The diagnostic usefulness of the history of the patient with dyspnea. 379 38

There is a group of patients who presents with intense anxiety and physical complaints suggestive of cardiac or gastrointestinal disease. These patients are more commonly women and complain of palpitations, lightheadedness, chest pains, and dyspnea. A work-up may reveal positive findings such as extrasystoles and mitral valve prolapse that appear to confirm the organic etiology of the symptoms. Evidence is presented that the positive findings serve to confuse the picture and are an impediment, rather than an aid, to the physician in making the correct diagnosis. Effective treatment using tricyclic antidepressants or monoamine oxidase inhibitors is suggested.
Gen Hosp Psychiatry 1985 Jul
PMID:Panics, prolapse, and PVCs. 401 78

This article discusses the causes of sleeplessness and its long-term management. Sleep may be repeatedly disturbed by pain, dyspnoea, micturition, or restlessness. The sleep patterns of the diseases which produce these symptoms are given, with an explanation in physiological terms of why they disturb sleep. A knowledge of these sleep patterns provides a valuable aid to diagnosis. It is concluded that there is only one condition, senility leading to senile dementia, for which long-term night sedation is justified.
J R Coll Gen Pract 1974 Aug
PMID:The clinical significance of disturbed sleep and the use of hypnotics. 437 78

Jumping is the most common reported means of suicide in general hospitals. There have been no published reviews of suicides of nonpsychiatric inpatients since 1980. We describe 12 subjects who, between January 1980 and January 1992, jumped from a large general teaching hospital. Eight of them succumbed, providing a rate of suicide of 1.7 per 100,000 admissions. There were three clinical subgroups: those admitted after suicide attempts, the acutely delirious, and the chronically medically ill. Factors appearing frequently in the third subgroup were pain, dyspnea, transient confusion, poor prognosis, and recent adverse news. When we compared the hospital jumpers with 30 nonfatal jumpers who attended our Emergency Department, the medical and psychiatric profiles differed in the frequency of medical illnesses, advancing age, male gender, and absence of preexisting psychiatric illness. Proximity and ease of access to balconies and windows appeared to be highly relevant to the prevention of hospital jumping.
Gen Hosp Psychiatry 1995 May
PMID:Jumping from a general hospital. 764 65

In view of the similarity between the reported effects of hyperventilation and recurrent functional symptom presented in primary care, a study was undertaken to establish whether such symptoms are attributable to hyperventilation. Twenty patients with two or more recurrent functional symptoms which their doctors found difficult to diagnose or treat, and 30 controls, were studied using symptom questionnaires and a series of hyperventilation provocation tests during which the partial pressure of carbon dioxide (PCO2) and symptoms were recorded. Sixteen cases (80%) had unexplained breathlessness compared with two of the controls (7%). All of the cases recognized familiar functional symptoms during provoked hyperventilation, and in 16 (80%), these included primary physical symptoms; only 23% of the controls recognized any previously experienced symptom. Considerable overlap of PCO2 values between groups meant that absolute values of PCO2 were not useful in differentiating between groups, but cases were more likely than controls to have a PCO2 of less than 4 kPa at rest, three minutes after hyperventilation, or during mental stress (75% of cases fulfilled one or more of these criteria versus 40% of controls). This is the first study in primary care to examine the effect of hyperventilation in a group of patients with multiple somatic symptoms. The findings have implications for the recognition and management of such patients.
Br J Gen Pract 1993 Oct
PMID:Hyperventilation in patients with recurrent functional symptoms. 826 Feb 21

The clinical features and distinguishing characteristics of the less common causes of chronic airflow obstruction have been reviewed. Clearly, the majority of patients have cigarette-induced chronic bronchitis and/or emphysema. However, for those patients with chronic airflow obstruction who are younger than 40 years old and/or have no or modest (less than 20 pack-years) smoking histories, a detailed assessment is warranted. A logical approach to the evaluation of the patient with dyspnea and chronic airflow obstruction has been outlined, with the goal of identifying those patients with potentially reversible disease, and to underscore the fact that not all "COPD" is due to cigarette smoking.
J Gen Intern Med 1993 Oct
PMID:Chronic obstructive pulmonary disease: less common causes--an algorithm for the primary care physician. 827 Oct 90


1 2 3 4 5 6 7 8 9 Next >>